CALLEGARI, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 4.022
AS - Asia 1.875
EU - Europa 1.312
SA - Sud America 244
Continente sconosciuto - Info sul continente non disponibili 104
AF - Africa 44
OC - Oceania 3
Totale 7.604
Nazione #
US - Stati Uniti d'America 3.914
SG - Singapore 697
CN - Cina 462
IT - Italia 333
DE - Germania 237
VN - Vietnam 211
BR - Brasile 183
PL - Polonia 165
HK - Hong Kong 137
GB - Regno Unito 113
UA - Ucraina 100
FI - Finlandia 98
BD - Bangladesh 96
TR - Turchia 64
CA - Canada 55
FR - Francia 51
ID - Indonesia 45
RU - Federazione Russa 38
IN - India 37
MX - Messico 36
JP - Giappone 35
SE - Svezia 32
AR - Argentina 25
NL - Olanda 22
RO - Romania 22
ES - Italia 19
CZ - Repubblica Ceca 16
ZA - Sudafrica 14
IQ - Iraq 13
AT - Austria 12
PK - Pakistan 12
LT - Lituania 9
UZ - Uzbekistan 9
VE - Venezuela 9
BE - Belgio 8
CO - Colombia 8
GR - Grecia 8
OM - Oman 7
EG - Egitto 6
IE - Irlanda 6
IR - Iran 6
KE - Kenya 6
CH - Svizzera 5
EC - Ecuador 5
IL - Israele 5
KR - Corea 5
SA - Arabia Saudita 5
BO - Bolivia 4
HU - Ungheria 4
JM - Giamaica 4
LB - Libano 4
PY - Paraguay 4
TN - Tunisia 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CL - Cile 3
HN - Honduras 3
JO - Giordania 3
NP - Nepal 3
AM - Armenia 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
DZ - Algeria 2
HR - Croazia 2
LV - Lettonia 2
MA - Marocco 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
AL - Albania 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BH - Bahrain 1
BJ - Benin 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GP - Guadalupe 1
GT - Guatemala 1
GY - Guiana 1
LA - Repubblica Popolare Democratica del Laos 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
TT - Trinidad e Tobago 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.502
Città #
Ashburn 513
Fairfield 456
Singapore 430
San Jose 317
Woodbridge 260
Houston 217
Warsaw 164
Seattle 163
Beijing 155
Wilmington 149
Chandler 144
Munich 141
Ann Arbor 139
Cambridge 135
Santa Clara 134
Hong Kong 132
Jacksonville 110
New York 91
Ferrara 79
Los Angeles 71
Ho Chi Minh City 67
Helsinki 53
Milan 48
Dallas 43
Council Bluffs 42
Hanoi 41
Nanjing 41
Izmir 39
Jakarta 37
Shanghai 36
San Diego 35
Tokyo 35
Princeton 33
Lauterbourg 31
London 29
Bologna 26
Rome 25
São Paulo 23
Nanchang 20
Chicago 19
Boardman 18
Jinan 18
Turku 18
Mexico City 17
Orem 17
Timisoara 17
Atlanta 16
Montreal 16
Toronto 16
Turin 16
Buffalo 14
Brno 13
Denver 11
Nuremberg 11
Addison 10
Boston 10
Brooklyn 10
Dearborn 10
Manchester 10
Moscow 10
Phoenix 10
San Francisco 10
Shenyang 10
The Dalles 10
Da Nang 9
Frankfurt am Main 9
Hangzhou 9
Hefei 9
Washington 9
Belo Horizonte 8
Dong Ket 8
Falls Church 8
Haiphong 8
Johannesburg 8
Mountain View 8
Stockholm 8
Tampa 7
Tashkent 7
Vancouver 7
Brussels 6
Changsha 6
Dublin 6
Düsseldorf 6
Hebei 6
Querétaro 6
Ankara 5
Auburn Hills 5
Berkeley 5
Chennai 5
Des Moines 5
Guangzhou 5
Hyderabad 5
Jiaxing 5
Kunming 5
Leeds 5
Ningbo 5
Norwalk 5
Paris 5
Poplar 5
Salt Lake City 5
Totale 5.274
Nome #
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 403
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 302
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 301
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 292
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 266
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 256
Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag 250
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 244
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 241
MicroRNA involvement in hepatocellular carcinoma 240
Quantification of circulating miRNAs by droplet digital PCR: Comparison of EvaGreen- and TaqMan-based chemistries 231
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 225
In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis 221
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 218
Animal Models of Hepatocellular Carcinoma Prevention 217
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy 213
p53/MDM2 Feed-back Loop Sustains miR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma 210
Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma 210
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 205
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B 199
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 195
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 195
MicroRNA response to environmental mutagens in liver 195
Circulating microRNAs as biomarkers for stratifying different phases of liver cancer progression and response to therapy 194
Emerging role of microRNAs in the treatment of hepatocellular carcinoma 188
Associations of risk factors obesity and occupational airborne exposures with CDKN2A/p16 aberrant DNA methylation in esophageal cancer patients 187
Inhibiting the oncogenic mir-221 by microRNA sponge: Toward microRNA-based therapeutics for hepatocellular carcinoma 173
MicroRNAs in Animal Models of HCC 162
Novel Virus Identification through Metagenomics: A Systematic Review 148
Erratum: miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 139
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 133
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 131
Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA 115
null 107
null 103
null 89
null 63
Role of microRNAs in hepatocellular carcinoma: a clinical perspective 62
Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer 61
The Effects of Variant Allele Frequency for EGFR Mutation on Early Tumor Shrinkage and Deepness of Response to Osimertinib in Patients with Metastatic Non-Small Cell Lung Cancer: An Exploratory Analysis 20
Totale 7.604
Categoria #
all - tutte 31.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.103


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022399 13 38 52 18 10 29 22 22 17 25 40 113
2022/2023344 32 19 19 46 47 42 40 25 41 0 21 12
2023/2024305 15 35 15 6 21 77 11 39 6 6 7 67
2024/20251.183 30 25 77 35 121 143 61 63 235 114 139 140
2025/20262.855 301 67 189 290 414 176 420 167 275 283 181 92
2026/202759 59 0 0 0 0 0 0 0 0 0 0 0
Totale 7.604